- Vertex makes $10B deal for commercial endocrinology biotech Crinetics Endpoints News
- Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms STAT
- Vertex’s $10B Crinetics deal marks its clearest step yet toward biopharma’s top ranks Endpoints News
- Vertex to acquire Crinetics in $10B foray into endocrine disease drugs BioPharma Dive
- Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion WSJ
